It is now understood that the nonclassical major histocompatibility complex-I molecule FcRn binds albumin and retrieves it from an intracellular degradative fate. Whether FcRn in the liver modulates albumin turnover through effects on biosynthesis and production is not known. Thus we quantified the appearance of biosynthetically labeled albumin in plasma after an intravenous bolus injection of [ 3 H]leucine in FcRndeficient mice. The production rates for both albumin (FcRn substrate) and transferrin (nonsubstrate) are increased by ϳ20% in FcRndeficient mice compared with normal mice, likely compensating for the lowered plasma oncotic pressure caused by hypoalbuminemia in FcRn-deficient mice. Determining the magnitude of FcRn-mediated effects on albumin turnover, we then measured the steady-state plasma concentrations of biosynthetically labeled albumin and transferrin during [ 3 H]leucine infusion. The concentration of albumin was ϳ40% lower in FcRn-deficient mice compared with normal mice. Furthermore, the ϳ40% lower plasma albumin concentration in FcRndeficient mice along with the ϳ20% increase in albumin production indicate, by the mass-balance equation, that albumin degradation in FcRn-deficient mice is twice that of normal mice. These studies of biosynthetically labeled, and thus native, albumin support our previous finding that FcRn protects albumin from degradation. Permitting quantification of the magnitude of FcRn-mediated recycling, they further indicate that FcRn has extraordinary capacity: the amount of albumin saved from degradation by FcRn-mediated recycling is the same as that produced by the liver. production; clearance; steady-state; kinetics; Fc receptor ALBUMIN and IGG, the two most abundant proteins in plasma, bind at low pH with high affinity to independent sites on the major histocompatibility complex-related Fc receptor (FcRn). Situated in acidic endosomes of virtually all nucleated cells, FcRn binds both ligands after they have been constitutively endocytosed, shunting them back to the pH-neutral cell surface for continuing circulation, thereby rescuing them from their usual lysosomal degradation fate. FcRn-deficient mice that lack such an FcRn-mediated recycling process (13) show shorter half-lives and lower steady-state plasma concentrations (Css) of both proteins than do normal mice (8).From our earlier measurements of radioiodinated albumin clearance (CL) and endogenous Css, we had inferred that the production rate (Rp) of albumin, using the mass-balance equation (Rp ϭ CL ϫ Css), was lower in the FcRn knockout (KO) strain compared with the wild-type (WT) strain (8). However, we acknowledged the estimations of CL for radioiodinated albumin to be only qualitative, for such measurements for albumin have historically been fraught with imprecision due to structural and/or functional alterations induced by purification and iodination (32). In fact, we had anticipated finding a greater albumin Rp in KO mice, for it had long been known that hypoalbuminemia induces an upregulation of the synth...